Stephen Nuckolls, CEO of Coastal Carolina Quality Care, explained during his presentation at the National Association of Accountable Care Organizations Spring 2016 Conference that the more physicians read and learn about value-based care, the more they are accepting the change. He added that as the idea has become more accepted, ACOs are beginning to evolve as well.
Stephen Nuckolls, CEO of Coastal Carolina Quality Care, explained during his presentation at the National Association of Accountable Care Organizations Spring 2016 Conference that the more physicians read and learn about value-based care, the more they are accepting the change. He added that as the idea has become more accepted, accountable care organizations (ACOs) are beginning to evolve as well.
Transcript (slightly modified)
Is it getting easier to sell physicians on the idea of ACOs and value-based care?
It definitely is. Our physicians and our group, they definitely follow some of the media and the journals that they read and they know that Medicare must move to more of a value-based world. And so the more things that they read, I think they feel more comfortable with it. Our organization has been at this awhile. We were one of the first 27 ACOs and one of the first 5 that were named as an advancement payment model so they’ve been at it for a while.
I think it definitely helps with MACRA [Medicare Access and CHIP Reauthorization Act] and some of the other new initiatives coming down the pipe. I think that it helps with engagement to know that they really need to focus on the efforts that we have and expand to new efforts from the ones that we’ve done in the past.
As one of the first ACOs, what have been your big lessons learned over the last few years?
Well, it’s been a constant evolution. We start off with the advanced payment funds, which allowed us to provide a very robust care coordination program. Since we did not achieve savings, we transitioned to the CCM, or chronic care management, codes that CMS afforded at the beginning of 2015. So we’ve had to change our program.
With that change came a lot of different focus on our efforts. Also, as we have evolved over time some of the quality measures and areas of focus in the beginning, we’ve reached our goals and so we have moved on to other measures that needed more attention. So the focus in some cases has moved from what I would call the process measures and to more outcomes measures in the last year or so.
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More